HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Mark Selected Research

Michael Mark Research Topics

Disease

12Type 2 Diabetes Mellitus (MODY)
12/2023 - 03/2003
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 05/2016
5Neoplasms (Cancer)
05/2024 - 01/2020
5Body Weight (Weight, Body)
07/2016 - 01/2012
4Inflammation (Inflammations)
01/2018 - 01/2008
3Prostatic Neoplasms (Prostate Cancer)
11/2022 - 12/2016
3Obesity
01/2021 - 01/2012
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2020
2Fibrosis (Cirrhosis)
01/2018 - 09/2014
2Pneumonia (Pneumonitis)
12/2016 - 09/2012
2Insulin Resistance
02/2016 - 01/2012
2Alcoholic Fatty Liver
09/2014 - 07/2010
2Breast Neoplasms (Breast Cancer)
03/2013 - 09/2012
2Wounds and Injuries (Trauma)
07/2012 - 06/2005
1Nausea
05/2024
1Edema (Dropsy)
05/2024
1Colitis
02/2024
1Hepatitis
02/2024
1Disease Progression
10/2022
1Lung Neoplasms (Lung Cancer)
10/2022
1Pain (Aches)
02/2021
1Chronic Renal Insufficiency
01/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
12/2016
1Mesothelioma
12/2016
1Malignant Mesothelioma
12/2016
1Heart Failure
07/2016
1Brain Neoplasms (Brain Tumor)
05/2016
1Dyslipidemias (Dyslipidemia)
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2014
1Weight Loss (Weight Reduction)
10/2014

Drug/Important Bio-Agent (IBA)

14LinagliptinIBA
12/2023 - 12/2007
10Dipeptidyl-Peptidase IV InhibitorsIBA
01/2020 - 12/2007
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2012
5Glucagon-Like Peptide 1 (GLP 1)IBA
10/2014 - 03/2003
3durvalumabIBA
02/2024 - 05/2021
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 12/2016
3Sodium-Glucose Transporter 2 InhibitorsIBA
01/2020 - 01/2016
3empagliflozinIBA
02/2016 - 01/2014
3Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
10/2014 - 04/2008
3Insulin (Novolin)FDA Link
04/2014 - 03/2003
2CreatinineIBA
05/2024 - 01/2021
2Docetaxel (Taxotere)FDA Link
10/2021 - 12/2016
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2012
2SodiumIBA
02/2016 - 01/2014
2Transcription Factors (Transcription Factor)IBA
12/2014 - 09/2014
2LiraglutideFDA Link
10/2014 - 03/2003
2Exenatide (Byetta)FDA Link
04/2014 - 01/2012
2XanthineIBA
07/2013 - 12/2007
2VildagliptinIBA
02/2009 - 04/2008
2purineIBA
02/2009 - 04/2008
1capmatinibIBA
05/2024
1NivolumabIBA
05/2024
1Lipase (Acid Lipase)FDA Link
02/2024
1RNA (Ribonucleic Acid)IBA
10/2022
1Messenger RNA (mRNA)IBA
10/2022
1RogaratinibIBA
10/2022
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2022
1B7-H1 AntigenIBA
05/2021
13-butylidene-4,5-dihydroxyphthalide (BP 42)IBA
02/2021
1binimetinibIBA
01/2021
1Pemetrexed (MTA)FDA Link
01/2021
1AlbuminsIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1Angiotensin Receptor AntagonistsIBA
01/2020
1KetonesIBA
01/2020
1lisavanbulinIBA
01/2020
1Prostate-Specific Antigen (Semenogelase)IBA
01/2019
1abirateroneIBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1Choline (Choline Chloride)IBA
01/2018
1Amino AcidsFDA Link
01/2018
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2018
1Lysophosphatidic Acid ReceptorsIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2017
1PM 01183IBA
12/2016
1orteronelIBA
12/2016
1AndrogensIBA
12/2016
1Uric Acid (Urate)IBA
07/2016
1Sodium-Glucose Transport ProteinsIBA
07/2016
1Carboplatin (JM8)FDA LinkGeneric
05/2016
1Paclitaxel (Taxol)FDA LinkGeneric
05/2016
1SymportersIBA
02/2016
1LDL CholesterolIBA
01/2016
1Dynorphins (Dynorphin)IBA
10/2014
1Appetite Depressants (Anorectics)IBA
10/2014
1IncretinsIBA
10/2014
1NicotineFDA Link
10/2014

Therapy/Procedure

8Therapeutics
01/2021 - 07/2010
3Castration
11/2022 - 12/2016
3Drug Therapy (Chemotherapy)
10/2021 - 10/2010
2Oral Administration
01/2018 - 07/2012
2Glycemic Control
07/2016 - 02/2016
1Immunotherapy
05/2024
1Neoadjuvant Therapy
10/2021
1Cranial Irradiation
01/2020
1Combined Modality Therapy
12/2016
1Radiotherapy
12/2016